Navigation Links
Next-gen reappraisal of interactions within a cancer-associated protein complex

KANSAS CITY, MO- At a glance, DNA is a rather simple sequence of A, G, C, T bases, but once it is packaged by histone proteins into an amalgam called chromatin, a more complex picture emerges. Histones, which come in four subtypesH2A, H2B, H3, and H4can either coil DNA into inaccessible silent regions or untwist it to allow gene expression. To further complicate things, small chemical flags, such as methyl groups, affect whether histones silence or activate genes.

Among activator histones is a form of H3 decorated at a precise location (defined as H3K4) with three methyl groups (known as "H3K4me3"). Researchers knew previously that the presence of H2B exhibiting a single ubiquitin molecule stimulated the methylase that modifies H3K4, thereby increasing H3K4me3 levels. But how the methylase's activity was directed toward the appropriate targets had remained unclear.

Now, using biochemical, structural, and global sequencing techniques, researchers in the lab of Ali Shilatifard, Ph.D., an Investigator at the Stowers Institute for Medical Research, reveal an unanticipated mechanism underlying H3K4 trimethylation. Their study, published in the January 15, 2014 issue of Genes & Development, explains why H3K4me3 is deposited adjacent to a target gene promoter rather than haphazardly across the entire gene. This finding is significant because mutations in the human gene encoding the methylase responsible for H3K4me3 are associated with childhood leukemias, among other malignancies.

The work also illustrates the way powerful new genome-wide sequencing methodologies are impacting all molecular biology, including cancer research. "Here, we show that one cannot rely on methods that simply measure overall bulk H3K4me3 levels in vitro," says Shilatifard. "Only genome-wide sequencing could have revealed that H3K4 trimethylation was promoter-specific in non-mutant yeast."

This means that many assumptions about gene expression may need to be retested using next-generation approaches. "The old technologies were like observing just one region of the earth from a distant telescope in space and then making assumptions about what the entire earth looked like," Shilatifard says. "With new technologies, we can now see the whole planet."

The methylase in question, named SET1 in yeast and MLL in mammals, is part of a protein aggregate called COMPASS, for COMplex of Proteins ASsociated with Set1. Shilatifard was the first to define the role of COMPASS in chromatin modification. "Over a decade ago, our lab used yeast to show that COMPASS was an H3 methylase," he says. "Since these fundamental systems are highly conserved from yeast to Drosophila to humans, we took advantage of the awesome power of yeast genetics to identify what regulates H3K4 methylation activity."

Part of the paper addresses SET1/MLL regulation by different proteins within yeast COMPASS. Investigators knew that if you lopped off more than half of SET1's front end, levels of DNA-bound trimethylated H3K4 in cells harboring the remaining "stub" were equal to those in cells containing the full-length protein when analyzed in bulk. This led some to presume that the entire front end of SET1/MLL, as well as factors that interact with it, must not be needed to regulate H3K4me3 activity.

The new paper shows that this presumption was not correct. The Shilatifard team first employed biochemical methods to capture every piece of DNA bound to H3K4me3 in the genome of yeast harboring either full-length SET1 or the stub missing the front end. They then sequenced all of those DNA fragments and mapped their position in the yeast genome.

Significantly, they found that even though H3K4me3 levels in bulk were equivalent in normal and mutant cells, H3K4me3 was differentially distributed throughout the genome: in normal cells, H3K4me3 complexes sat primarily on DNA regions that switch adjacent genes on or off, control regions called promoters. By contrast, the DNA of cells harboring the stub exhibited DNA-binding H3K4me3 complexes in the middle of or between genes.

These discoveries, combined with other findings, call for re-interpretation of data suggesting that the stub is all you need for H3K4 trimethylation. Instead, the new work shows that COMPASS factors that bind to the SET1/MLL front end limit H3K4me3 deposition to the correct genomic sites (that is, to the promoter regions), while factors that bind the SET1/MLL stub increase the protein's half-life. This partially explains earlier misinterpretations: highly stable stubs of SET1 "promiscuously" methylated the wrong parts of the genome when the regulatory front end of the protein was missing. The paper also addressed how H2B ubiquitin modification machineries stimulate the entire process.

Understanding COMPASS regulation is essential, as genes encoding factors in the complex are mutant in numerous cancers. For example, chromosomal translocations involving a gene encoding one MLL protein occur frequently in human leukemias, hence the designation MLL, which stands for Mixed Lineage Leukemia protein. Other MLL proteins are strongly implicated as tumor suppressors in human cancers such as lymphoma and pediatric brain tumors.

Contact: Gina Kirchweger
Stowers Institute for Medical Research

Related biology news :

1. LABS, Inc. Launches Suite of Next-Generation Test Offerings; Focuses on Expanding Complex Biologic Testing Portfolio in 2012
2. Next-generation sequencing technology opens doors to discoveries
3. RIT leads development of next-generation infrared detectors
4. UT Dallas researchers awarded $4.3 million to create next-generation technologies
5. Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show
6. Droplet Digital™ PCR provides accurate quantification of next-generation sequencing libraries
7. Next-gen sequencing identifies genes associated with speech disorder
8. TGen-led research shows ability to do next-generation sequencing for patients with advanced cancers
9. Next-generation global e-infrastructure for taxon names registry
10. Allen Institute for Brain Science partners with imec for development of next-generation tools
11. Sanford-Burnham receives US Air Force grant to perform next-generation toxicity screens
Post Your Comments:
Related Image:
Next-gen reappraisal of interactions within a cancer-associated protein complex
(Date:10/9/2015)... ) ... "Samsung Galaxy S6 Fingerprint Sensor - Reverse ... --> ) has announced ... S6 Fingerprint Sensor - Reverse Costing Analysis" ... Research and Markets ( ) ...
(Date:10/8/2015)... 8, 2015 NXT-ID, Inc. ... a biometric authentication company focused on the growing ... smart wallet announces that revenues for the three ... compared with $113,00 for the three months ended ... ended September 30, 2015 were approximately $520,000. ...
(Date:10/6/2015)... CITY , Oct. 6, 2015 Track ... announced today that it has signed a contract with ... services across the full range of sentences under the ... President of the Americas. "This contract with the Virginia ... of the US and advances our position as a ...
Breaking Biology News(10 mins):
(Date:10/13/2015)... ... October 13, 2015 , ... Clinovo recently appointed Jeff Parr and Ed Donaldson ... clinical data solutions business. , Jeff Parr has spent the past decade providing quality ... Dennison, Thermo Fisher, and Ab Sciex to name a few. He is based ...
(Date:10/13/2015)... , ... October 13, 2015 , ... ... educational opportunities for school age children in the areas of Science, Technology, Engineering ... sectors of the national economy, and the program aims to increase the number ...
(Date:10/12/2015)... ... October 12, 2015 , ... Spirax Sarco, the leader in products and services ... 600 compact clean steam generator . This unit is a skid mounted system ... HTM2010, and EN285 standards. The CMS-C 600 generator can produce up to a ...
(Date:10/12/2015)... , Oct. 12, 2015  Rebiotix Inc. today ... has designated its lead Microbiota Restoration Therapy (MRT) ... of recurrent Clostridium difficile (C diff) ... that causes 29,000 deaths in the U.S. annually. ... company that was founded to revolutionize the treatment ...
Breaking Biology Technology: